AZ BNT
mRNA mRNA
2 1 2 2 2
8-12 --- 28 21
ACIP 28 28
ACIP:
AZ BNT
54.2% 48.6% 92.0% 84.1% 71.2%
53.1% 38.2% 70.0% 62.9% 36.0%
52.6% 38.9% 64.7% 55.1% 22.0%
44.0% 33.2% 61.5% 38.3% 27.6%
7.9% 9.0% 15.5% 14.2% 0.7%
0.3( )
10(
BNT
Moderna
AZ
(J&J) RWD 38 BNT
66%
80%
AZ 61%
79%
100% 100%
BNT 95%
Moderna 94.1%
AZ 70%
J&J 66.9%
Alpha (B.1.1.7) BNT 95%
預防住院AZ 86%
預防住院Delta (B.1.617.2) BNT 96%
預防住院AZ 92%
預防住院Nat Med. 2021 Jun 9.
healthydebate.ca Public Health England
這邊一直都會有新資料出來
就先看個大概吧
2
4-28
1. )
2. 24 )
3. )
4. )
5.
CDC
/ / / / / / /
/ / / / ?
<18
( )
AZ
CDC
mRNA mRNA AZ
( )
BMI>40 45
,
N Engl J Med. 2021 Apr 21;NEJMoa2104983 CDC
/
CDC
-
March 9, 2021 | NOF in the News, Statement
-
COVID-19
( )
Mycophenolate 1
Methotrexate mRNA 1
(J&J) 2 JAKi (Upadacitinib,
Barcitinib,Tofacitinib Peficitinib)
1
Abatacept SQ
1
Abatacept IV
abatacept 4
1 abatacept
Cyclophosphamide
IV 1
Rituximab (
)
rituximab 4
rituximab 2-4
Acetaminophen,
NSAIDs 24
Apremilast Azathioprine Belimumab(po)
Cyclophosphamide (po) Calcineurin inhibitors Hydroxychloroquine IVIG
Leflunomide Prednisone Sulfasalazine TNFi; IL-6R;
IL-1;IL-17;
IL-12/23; IL-23 American College of Rheumatology. COVID-19 vaccine clinical guidance summary for
patients with rheumatic and musculoskeletal diseases. (2021.02)
1st疫苗
4週 4週
4週 １週
4週
1st疫苗
6M 6M
4週
2-4週
2nd疫苗
NCCN Version 2.0 03/10/2021
減毒活性疫苗
口服輪狀病毒（rotavirus）
黃熱病（yellow fever）
口服小兒麻痺（oral polio vaccine，OPV）
水痘（varicella）
卡介苗（BCG）
麻疹德國麻疹腮腺炎三合一（MMR）
